*By Conor White* Europe has a new unicorn. The London-based fintech company Revolut announced last month it raised $250 million in Series C funding, bumping its valuation to $1.7 billion. Revolut will use some of that money to jump across the pond to the United States. "Given how aggravated people are with banking in general, we believe there's a huge market to go into the U.S. and cause serious disruption," said the Revolut chief marketing officer, Chad West. "So a huge amount of this capital will be expanding ourselves into the U.S., and building a real, innovative team out there." In just 36 months, Revolut has raised $340 million, signed up more than 2 million customers in Europe, and has its sites set on conquering America and challenging companies like Robinhood. "Right now Robinhood is purely on that road of wealth management and investments," West said Friday in an interview with Cheddar. "When Revolut comes to the U.S.A, there's nothing quite like us. We are the definition of a challenger bank." For the full interview, [click here](https://cheddar.com/videos/london-based-fintech-revolut-plots-route-to-u-s).

Share:
More In Technology
Need2Know: Ukraine Aid Package, GDP Shrinks & Beijing Lockdown
Catching you up on what you need to know on April 29, 2022, with President Biden asking Congress for a $33 billion aid package for Ukraine, a shrinking GDP potentially leading to a recession, Beijing banning weddings and funerals while closings schools amid COVID, and more.
CVS Health Backs Virtual Care and Digital Medicine Provider Biofourmis in $300 Million Funding Round
Virtual care and digital medicine provider Biofourmis recently raised $300 million in a Series D round led by General Atlantic and with participation from CVS Health. Biofourmis offers at-home care and digital therapies backed by artificial intelligence, which can remotely monitor patients while they are at home. The company says it hopes its technology can improve patient outcomes while reducing the cost and burden of care. Kuldeep Signh Rajput, Founder and CEO of Biofourmis, joins Cheddar News' Closing Bell to discuss.
Technological Breakthrough in Head Injury Prevention
Dr. Michael Bottlang and Dr. Steve Madey, co-founders of WaveCel, join Cheddar Innovates to share their breakthrough in hard hat design that could have ramifications for protecting against head trauma across industries.
3D Printing Meets Vitamins
Melissa Snover, Founder & CEO of Nourished, joins Cheddar Innovates to discuss her one-of-a-kind business that offers customizable, 3D printed vitamins that offer less hassle, cost, and waste than traditional vitamins.
Load More